Skip to content

Randomized clinical trial comparing sodium sulfate with sodium phosphate solution in the preparation for colonoscopy

Randomized clinical trial comparing sodium sulfate with sodium phosphate solution in the preparation for colonoscopy, single center?blind and parallel control study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11003080
Enrollment
Unknown
Registered
2011-08-01
Start date
2011-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon and rectum diseases

Interventions

experimental:4 hours prior to colonoscopy (4:00 for patients to be examined in the morning , 8:00 for patients to be examined in the afternoon), patients of sodium sulfate group orally took medical mi
control:control group(CG): patients of sodium phosphate group at the same time took one dose of oral FLEET solution(45ml/bottle) before took in 750 ml water, and repeat the procedure once 1 hour after

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. age ranged from 18 to 65 years old; 2. both male and female; 3. signed informed consent; 4. fulfil patient's diary.

Exclusion criteria

Exclusion criteria: 1. refused informed consent; 2. cann't fulfil patient's diary; 3. usage of laxatives?antidiarrheal drugs or gastroprokinetic agents in recent 1 week; 4. patients with intestinal obstruction, perfusion, gastric retention, active hemorrhage of GI tract, toxic enteritis, toxic megacolon, volvulus or severe ulcerative colitis; 5. gestation or lactation; 6. severe cardiac insufficiengcy, ALT above 2.5 times of upper limit?Creatinine abnormality; 7. hemopoietic diseases or endocrine system diseases; 8. psychiatirc diseases; 9. attended other trials 3 months ago; 10. allergic character or allergic to the medicine or element of the medicine; 11. suspected or have abuse of alcohol or drugs; 12. patients with bad compliance.

Design outcomes

Primary

MeasureTime frame
grade of bowel cleanliness based on the amount of fecal residue;grade of bowel cleanliness based on presence of foam in colon;

Secondary

MeasureTime frame
acceptability of bowel preparation;accompanying symptom;

Countries

China

Contacts

Public ContactChengwei Tang
shcqcdmed@163.com+86 18980601275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026